Skip to content
Explore our new Pα+ Psychedelic Bill Tracker.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

  • Post published:July 30, 2020
  • Post category:Press Release
Read more about the article Yield Growth Closes $1.4 Million Financing

Yield Growth Closes $1.4 Million Financing

  • Post published:July 30, 2020
  • Post category:Press Release
Read more about the article Palliative Canadians await August 4th decision on psilocybin mushroom  approval – TheraPsil urges Health Minister to ‘do the right thing’  

Palliative Canadians await August 4th decision on psilocybin mushroom  approval – TheraPsil urges Health Minister to ‘do the right thing’  

  • Post published:July 30, 2020
  • Post category:Press Release
Read more about the article Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness

Numinus and Together We Can Partner to Support Addiction Recovery and Mental Wellness

  • Post published:July 29, 2020
  • Post category:Press Release
Read more about the article Empower Clinics Announces the Revocation of Cease Trade Order

Empower Clinics Announces the Revocation of Cease Trade Order

  • Post published:July 29, 2020
  • Post category:Press Release
Read more about the article MindMed Completes Dosing 18-MC Phase 1 Study

MindMed Completes Dosing 18-MC Phase 1 Study

  • Post published:July 28, 2020
  • Post category:Press Release
Read more about the article Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent

Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent

  • Post published:July 27, 2020
  • Post category:Press Release
Read more about the article Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

  • Post published:July 25, 2020
  • Post category:Press Release
Read more about the article Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

  • Post published:July 25, 2020
  • Post category:Press Release
Read more about the article Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

  • Post published:July 24, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2026, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More